Skip to Contents

Skip to Contents

Meet Us at ISSX 2026

Meet Us at ISMB 2026

Meet Us at ISSX 2026.

Cross-species pharmacokinetic comparison and human PK prediction of HM15275, A novel long-acting GLP-1/GIP/GCG triple agonist for treatment of obesity
Presentation Number
P120
Session
Poster Session 2, Jul. 2 at 12:00-12:45 PM
Presenter
Sunyoung Lim /
Hanmi Pharm. Co., Ltd.

Meet Us at ISMB 2026.

HARP-pSAR: A pLM-based Framework for Protein Fitness Landscapes in Practical Drug Discovery
Presentation Number
D-008
Session
Session D, Jul. 16 at 10:00-11:00 AM & 16:00-16:40 PM
Presenter
Seungsu Han, Ph.D /
Hanmi Pharm. Co., Ltd.

Hanmi's New Story

Creativity, Innovation, and Challenge
A New Era Takes Off at Hanmi

Focus on Making
Innovative Medicines

Hanmi Pharmaceutical is leading innovation in the
pharmaceutical industry with a sustainable R&D
infrastructure covering various therapeutic areas.

Obesity/Metabolism

Developing best-in-class drugs for obesity,
non-alcoholic steatohepatitis,
and more with multiple mechanisms of action

View More

ESG Report

Hanmi ESG is Everyday-life Innovation

View More

Your dream is our future.
Hanmi awaits you.

Join Us